|
|
|
Volumn 6, Issue 11, 2003, Pages 1049-1052
|
|
Inflammatory Processes in Drug Discovery - SRI Conference: 22-23 September 2003, Philadelphia, PA, USA
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
5 (2,6 DICHLOROPHENYL) 2 (2,4 DIFLUOROPHENYLTHIO)PYRIMIDO[1,6 B]PYRIDAZIN 6 ONE;
ACETYLSALICYLIC ACID;
AMPHOTERICIN B;
ANTIINFLAMMATORY AGENT;
BMS 345541;
BRUTON TYROSINE KINASE;
COCHLEATE;
CYCLOSPORIN A;
CYTOKINE;
CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;
DORAMAPIMOD;
DRUG CARRIER;
INHIBITORY KAPPA B KINASE INHIBITOR;
INHIBITORY KAPPA B KINASE RELATED KINASE INHIBITOR;
INTERLEUKIN 1BETA CONVERTING ENZYME INHIBITOR;
LJP 1200;
LJP 1207;
LJP 1233;
MONOAMINE OXIDASE INHIBITOR;
MP 8;
PARACETAMOL;
PRALNACASAN;
PROTEIN KINASE;
PROTEIN KINASE INHIBITOR;
RO 3304406;
SEMICARBAZIDE SENSITIVE AMINE OXIDASE INHIBITOR;
SYNAPTOPHYSIN KINASE INHIBITOR;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VX 702;
VX 765;
ARTHRITIS;
CANDIDIASIS;
CLINICAL TRIAL;
COLITIS;
CONFERENCE PAPER;
CONTACT DERMATITIS;
CYTOKINE RELEASE;
DOSE RESPONSE;
DRUG BIOAVAILABILITY;
DRUG DELIVERY SYSTEM;
DRUG FORMULATION;
DRUG HALF LIFE;
DRUG MECHANISM;
DRUG POTENTIATION;
DRUG RESEARCH;
DRUG SELECTIVITY;
DRUG STRUCTURE;
ENCEPHALITIS;
GENE EXPRESSION;
GENE TARGETING;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEART TRANSPLANTATION;
HUMAN;
INFLAMMATION;
NONHUMAN;
OSTEOARTHRITIS;
PAW EDEMA;
PROTEOMICS;
PSORIASIS;
RHEUMATOID ARTHRITIS;
SEPSIS;
STOMACH DISEASE;
STOMACH HEMORRHAGE;
STOMACH ULCER;
SYMPOSIUM;
TRANSGENIC ANIMAL;
ADJUVANTS, IMMUNOLOGIC;
ANIMALS;
ANIMALS, GENETICALLY MODIFIED;
ANTI-INFLAMMATORY AGENTS;
ARTHRITIS, RHEUMATOID;
CLINICAL TRIALS, PHASE I;
CLINICAL TRIALS, PHASE II;
CYTOKINES;
DRUG DESIGN;
ENZYME INHIBITORS;
HUMANS;
INFLAMMATION;
PROTEOMICS;
SEPSIS;
|
|
EID: 0345392690
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (2)
|
|
References (0)
|
